Singer India gets NSE approval for listing of 6.22 crore equity shares; listing starting March 19Singer India gets NSE approval for listing of 6.22 crore equity shares; listing starting March 19

Introduction

Leading consumer goods company receives NSE approval to list 6,22,19,117 equity shares of ₹2 each, commencing trading from March 19, 2026 under the symbol SINGERIND.

Also Read: Power Mech Projects bags ₹709 crore Adani Group contract; stock jumps 5.5%

Share price movement of Singer India

On March 18, 2026, Singer India Ltd opened ₹75.99, up 2.70% from its previous close of ₹74.00. The stock reached a high of ₹77.78 (5.09%) and a low of ₹74.80. By 4:00 PM, it traded at ₹76.53, a 3.36% increase, with a market cap of ₹482.20 crore.

Singer India Shares to Get Listed on NSE

Singer India Limited has received approval from the National Stock Exchange of India for listing and trading 6,22,19,117 equity shares of face value ₹2 each.

The shares will be listed and admitted to trading on NSE from March 19, 2026, under the symbol “SINGERIND,” as per the official approval letter received by the company.

Stock performance of Singer India for period of 1 week, 6 months, and 1 year

Singer India Ltd delivered a 1-week return of -2.41%, a 6-month return of -19.2%, and a 1-year return of 31.6%.

Also Read: Andhra Cements jumps 10% as parent Sagar Cements announces OFS; check floor price

Shareholding pattern of Singer India

Particulars	Dec 2025	Sep 2025	Jun 2025
Promoter	30.80%	30.80%	30.80%
FII	0%	0%	0%
DII	0.80%	0.80%	0.80%
Public	68.50%	68.50%	68.50%

About Singer India

Singer India Ltd (BSE: 505729), incorporated in 1977, manufactures and trades sewing machines, related accessories, and domestic appliances, serving the home and industrial markets across India.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs